HOYA CORP. ADR/ 1 O.N. (HYB0) - Net Assets
Based on the latest financial reports, HOYA CORP. ADR/ 1 O.N. (HYB0) has net assets worth €971.63 Billion EUR (≈ $1.14 Trillion USD) as of March 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.23 Trillion ≈ $1.44 Trillion USD) and total liabilities (€262.65 Billion ≈ $307.06 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore HYB0 cash flow conversion to assess how effectively this company generates cash.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €971.63 Billion |
| % of Total Assets | 78.72% |
| Annual Growth Rate | 7.18% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 7.61 |
HOYA CORP. ADR/ 1 O.N. - Net Assets Trend (2022–2025)
This chart illustrates how HOYA CORP. ADR/ 1 O.N.'s net assets have evolved over time, based on quarterly financial data. Also explore HYB0 total asset value for the complete picture of this company's asset base.
Annual Net Assets for HOYA CORP. ADR/ 1 O.N. (2022–2025)
The table below shows the annual net assets of HOYA CORP. ADR/ 1 O.N. from 2022 to 2025. For live valuation and market cap data, see HYB0 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | €971.63 Billion ≈ $1.14 Trillion |
+0.97% |
| 2024-03-31 | €962.26 Billion ≈ $1.12 Trillion |
+18.13% |
| 2023-03-31 | €814.60 Billion ≈ $952.36 Billion |
+3.24% |
| 2022-03-31 | €789.06 Billion ≈ $922.49 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to HOYA CORP. ADR/ 1 O.N.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 8.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €871.36 Billion | 89.46% |
| Other Components | €102.67 Billion | 10.54% |
| Total Equity | €974.02 Billion | 100.00% |
HOYA CORP. ADR/ 1 O.N. Competitors by Market Cap
The table below lists competitors of HOYA CORP. ADR/ 1 O.N. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ambev S.A
MX:ABEVN
|
$50.44 Billion |
|
Rockwell Automation Inc
NYSE:ROK
|
$50.51 Billion |
|
Cencora Inc.
NYSE:COR
|
$50.53 Billion |
|
Fastenal Company
NASDAQ:FAST
|
$50.71 Billion |
|
Discover Financial Services
NYSE:DFS
|
$50.34 Billion |
|
GigaDevice Semiconductor(Beiji
SHG:603986
|
$50.25 Billion |
|
MetLife Inc
NYSE:MET
|
$50.18 Billion |
|
Electronic Arts Inc
NASDAQ:EA
|
$50.16 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in HOYA CORP. ADR/ 1 O.N.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 967,758,000,000 to 974,023,000,000, a change of 6,265,000,000 (0.6%).
- Net income of 202,102,000,000 contributed positively to equity growth.
- Dividend payments of 38,417,000,000 reduced retained earnings.
- Share repurchases of 150,012,000,000 reduced equity.
- New share issuances of 518,000,000 increased equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €202.10 Billion | +20.75% |
| Dividends Paid | €38.42 Billion | -3.94% |
| Share Repurchases | €150.01 Billion | -15.4% |
| Share Issuances | €518.00 Million | +0.05% |
| Other Changes | €-7.93 Billion | -0.81% |
| Total Change | €- | 0.65% |
Book Value vs Market Value Analysis
This analysis compares HOYA CORP. ADR/ 1 O.N.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.05x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-03-31 | €2201.68 | €150.00 | x |
| 2023-03-31 | €2311.72 | €150.00 | x |
| 2024-03-31 | €2760.91 | €150.00 | x |
| 2025-03-31 | €2841.72 | €150.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently HOYA CORP. ADR/ 1 O.N. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 20.75%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 22.82%
- • Asset Turnover: 0.72x
- • Equity Multiplier: 1.27x
- Recent ROE (20.75%) is above the historical average (20.14%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 20.46% | 24.54% | 0.68x | 1.24x | €84.12 Billion |
| 2023 | 20.61% | 22.97% | 0.71x | 1.26x | €86.81 Billion |
| 2024 | 18.74% | 22.88% | 0.66x | 1.24x | €84.60 Billion |
| 2025 | 20.75% | 22.82% | 0.72x | 1.27x | €104.70 Billion |
Industry Comparison
This section compares HOYA CORP. ADR/ 1 O.N.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $6,199,585,877
- Average return on equity (ROE) among peers: -8.85%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| HOYA CORP. ADR/ 1 O.N. (HYB0) | €971.63 Billion | 20.46% | 0.27x | $50.37 Billion |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $419.42 Million | 24.02% | 0.76x | $2.39 Billion |
| RENAU.UNSP.ARD 1/5 EO-20 (56S0) | $2.67 Billion | 11.61% | 1.89x | $15.47 Billion |
| MEDIMI AB AK (79T) | $13.75 Million | -103.63% | 0.50x | $365.27K |
| TEVANO SYSTEMS HLDGS INC. (7RBA) | $-938.43K | 0.00% | 0.00x | $210.67K |
| STEVANATO GROUP SPA O.N. (87N) | $841.66 Million | 15.96% | 0.69x | $894.98 Million |
| Carl Zeiss Meditec AG (AFX) | $2.06 Billion | 8.69% | 0.65x | $2.23 Billion |
| CARL ZEISS MEDITEC ADR 1 (AFXA) | $2.17 Billion | 13.36% | 0.40x | $2.14 Billion |
| Bio-gate AG (BIG1) | $1.79 Million | -90.74% | 1.21x | $7.08 Million |
| COLOPLAST SP.ADR 1/10 DK1 (CBH) | $17.94 Billion | 28.16% | 1.68x | $12.73 Billion |
| ESSILORLUXOTTICA 1/2/O.N. (ESLC) | $35.88 Billion | 4.04% | 0.66x | $78.07 Billion |
About HOYA CORP. ADR/ 1 O.N.
HOYA Corporation, a med-tech company, provides high-tech and medical products internationally. It operates through two segments: Life Care, and Information and Communications. It offers life care products, including eyeglasses and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning devices; and other medical related products, suc… Read more